Keeping up the weight loss

Just in time for the New Year's resolution. A randomised, double blind trial suggests that the drug, sibutramine, previously known for inducing dose-dependent weight loss and enhancing the effects of a low-calorie diets, is effective in sustaining weight loss (Lancet 2000; 356: 2119-25). The international team of researchers, lead by Professor W Philip T James from Aberdeen, UK, studied 605 obese patients recruited from eight European centres. The patients were enrolled in a 6-month period of we

By | December 29, 2000

Just in time for the New Year's resolution. A randomised, double blind trial suggests that the drug, sibutramine, previously known for inducing dose-dependent weight loss and enhancing the effects of a low-calorie diets, is effective in sustaining weight loss (Lancet 2000; 356: 2119-25).

The international team of researchers, lead by Professor W Philip T James from Aberdeen, UK, studied 605 obese patients recruited from eight European centres. The patients were enrolled in a 6-month period of weight loss treatment with sibutramine (10 mg/day) and an individualised dietary programme; 467 (77%) achieved more than 5% weight loss and were eligible for the second phase of the trial where they were randomly assigned either 10 mg/day of sibutramine (352 patients) or placebo (115 patients) for a further 18 months. Of the 204 sibutramine-treated patients who completed the trial, 89 (43%) maintained 80% or more of their original weight loss, compared with only nine (16%) of the 57 individuals receiving placebo.

Now the bad news; HDL-cholesterol concentrations (beneficial in protecting against heart disease) were greater in the sibutramine group (20.7% compared with 11.7%) and researchers were forced to withdraw 20 (3%) patients because of increases in blood pressure. Professor James says that patients receiving this drug should have their blood pressure monitored regularly to identify any unusual cardiovascular effects.

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech